Shortage of engineers preventing further sharing of vaccine technology, says AstraZeneca
AstraZeneca has said it does not have enough engineers to further share its vital Covid vaccine technology with other global manufacturers, as other pharmaceutical giants face growing pressure to relinquish their control over the production of the life-saving jabs.
Amid a global shortage of supplies, health campaigners have called on the likes of AstraZeneca, Pfizer, Moderna and others to waive their intellectual property (IP) rights and transfer vaccine manufacturing know-how to other companies capable of producing doses en masse.
Western markets have received the vast majority of jabs, with fewer than 1 per cent of doses administered in low-income countries by the end of March. Last month, theWorld Health Organisation warned there is an “urgent, near-term need to unlock additional Covid vaccine supply”.
Campaigners have said that the only way to address the current bottleneck in production – a number of companies, including AstraZeneca, have struggled to meet their early targets – is to share vaccine technology among manufacturers.
But AstraZeneca, which is not making a profit off its vaccine sales, has insisted it does not have the manpower to …
More on: www.independent.co.uk